Angevin E

References (1)

Title : Serum soluble CD26\/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody - Kaneko_2021_Biomark.Res_9_21

Author(s) : Kaneko Y , Hatano R , Hirota N , Isambert N , Trillet-Lenoir V , You B , Alexandre J , Zalcman G , Valleix F , Podoll T , Umezawa Y , Takao S , Iwata S , Hosono O , Taguchi T , Yamada T , Dang NH , Ohnuma K , Angevin E , Morimoto C

Ref : Biomark Res , 9 :21 , 2021

Abstract :

PubMedSearch : Kaneko_2021_Biomark.Res_9_21

PubMedID: 33757558

Angevin E

References (1)

1. Serum soluble CD26\/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody - Kaneko_2021_Biomark.Res_9_21